David Morris

发表

Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age

H. Ochs, E. Haddad, N. Patel, 2015, Journal of Clinical Immunology.

TREC Screening for WHIM Syndrome

J. Walter, D. McDermott, S. Jyonouchi, 2021, Journal of Clinical Immunology.

TREC Screening for WHIM Syndrome

J. Walter, D. McDermott, S. Jyonouchi, 2021, Journal of Clinical Immunology.

Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.

T. Torgerson, N. Patel, M. Thakar, 2023, Journal of clinical immunology.